Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
Not Confirmed
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us 
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BePharma
Not Confirmed
Contact SupplierBePharma
Industry Trade Show
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content
NEWS #PharmaBuzz
10 Feb 2021
// INVESTORROOM
https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc#:~:text=OAKVILLE%2C%20ON%2C%20Feb.%2010,of%20Brinavess%2C%20Aggrastat%20and%20Trevyent.
10 Feb 2021
// INVESTORROOM
https://cipher.investorroom.com/2021-02-10-Cipher-Pharmaceuticals-Enters-into-Co-Promotion-Agreement-with-Verity-Pharmaceuticals-Inc#:~:text=OAKVILLE%2C%20ON%2C%20Feb.%2010,of%20Brinavess%2C%20Aggrastat%20and%20Trevyent.
19 Oct 2019
// BIOSPACE
https://www.biospace.com/article/releases/cipher-pharmaceuticals-receives-health-canada-approval-for-trulance-and-174-plecanatide-/?s=95
11 Jul 2018
// Michael Mezher RAPS
https://www.raps.org/news-and-articles/news-articles/2018/7/arog-lands-opdp-untitled-letter-over-promotional-s?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2011%20July%202018
15 May 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/correvio-pharma-corp-completes-strategic-transaction-with-cipher-pharmaceuticals-300648550.html
https://www.prnewswire.com/news-releases/cipher-pharmaceuticals-and-cardiome-pharma-announce-strategic-transaction-for-canadian-business-portfolio-of-cardiome-677363803.html
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
Dosage Form : CAPSULE; ORAL
Proprietary Name : LIPOFEN
Dosage Strength : 50MG
Approval Date : 2006-01-11
Application Number : 21612
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : LIPOFEN
Dosage Strength : 100MG
Approval Date : 2006-01-11
Application Number : 21612
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : LIPOFEN
Dosage Strength : 150MG
Approval Date : 2006-01-11
Application Number : 21612
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : SUSPENSION; TOPICAL
Proprietary Name : NATROBA
Dosage Strength : 0.9%
Approval Date : 2011-01-18
Application Number : 22408
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : CONZIP
Dosage Strength : 100MG
Approval Date : 2010-05-07
Application Number : 22370
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : CONZIP
Dosage Strength : 200MG
Approval Date : 2010-05-07
Application Number : 22370
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : CONZIP
Dosage Strength : 300MG
Approval Date : 2010-05-07
Application Number : 22370
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : CONZIP
Dosage Strength : 150MG
Approval Date : 2011-08-01
Application Number : 22370
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
ABOUT THIS PAGE
Share 
